Adeprina Report issue

Foundation

Organization Overview

First Clinical Trial
2013
NCT02352740
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Adeprina

Active Ingredients

Drugs in Other Trials (1)

arginine (2 trials)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 1